Background illustration for clinical trials search

Paid Clinical Trials Provo

Discover 1,057 paid clinical trials in Provo, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
Location: Salt Lake City UT, Lone Tree CO, Gilbert AZ, Orange CA,
Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 18+

Code: NCT06163430

Phase 1, Phase 2, Recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

for
Advanced Solid Tumors
Location: Salt Lake City UT, Houston TX, Cincinnati OH
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT06096974

Phase 1, Recruiting

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Salt Lake City UT, Aurora CO, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05773274

Phase 2, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Salt Lake City UT, Lone Tree CO, Gilbert AZ,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

for
Breast Cancer Recurrent
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05464082

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

for
AIDS-Related Diffuse Large B-cell Lymphoma,
Location: Salt Lake City UT, Duarte CA, Chicago IL, Columbus OH,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05077527

Phase 1, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Salt Lake City UT, Lone Tree CO, Albuquerque NM,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase 2, Recruiting

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Salt Lake City UT, Nampa ID, Denver CO, Littleton CO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05058651

Phase 2, Phase 3, Recruiting

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Salt Lake City UT, Aurora CO, Gilbert AZ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase 2, Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Salt Lake City UT, Los Angeles CA, Seattle WA, Omaha NE,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase 2, Recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for
Breast Cancer
Location: Salt Lake City UT, Las Vegas NV, Boulder CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07062965

Phase 3, Recruiting

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

for
Plasma Cell Leukemia
Location: Salt Lake City UT, Baton Rouge LA, Buffalo NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07605416

Phase 2, Recruiting

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 18+

Code: NCT05613894

Phase 1, Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Salt Lake City UT, Sacramento CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06661915

Phase 2, Recruiting

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

for
Melanoma (Skin Cancer)
Location: Salt Lake City UT, Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07556380

Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Salt Lake City UT, Sacramento CA, Duarte CA, Orange CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06860594

Phase 1, Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Salt Lake City UT, Aurora CO, Phoenix AZ,
Sponsor: CarThera

Sex: All

Age: 18+

Code: NCT05902169

Phase 3, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Salt Lake City UT, Fresno CA, Roseville CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

for
Colo-rectal Cancer
Location: Salt Lake City UT, Kansas City KS, Iowa City IA,
Sponsor: NSABP Foundation Inc

Sex: All

Age: 18+

Code: NCT07058012

Phase 2, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Salt Lake City UT, Twin Falls ID, Boise ID, Meridian ID,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting